In general, it is known that serum levels of VEGF are associated with a poor prognosis in different tumor types (Zusterzeel et al. 2009; Komatsu et al. 2017; Kwon et al. 2010; Xuan et al. 2017). This evidence concerns the gene VEGFA and neoplasm.